Cirugia De Lux (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 27 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -26.12%
- Profit Growth -11.83%
- Ebitda -3.99%
- Net Worth 4.08%
- Total Assets -10.87%
About Cirugia De Lux (India)
Cirugia De Lux (India) Private Limited (CDLIPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 December 1997 and has a history of 27 years and one month. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nayana Puri and Harish Puri serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U29297MH1997PTC112177
- Company No.
112177
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Cirugia De Lux (India) Private Limited offer?
Cirugia De Lux (India) Private Limited offers a wide range of products and services, including Metallurgical & Lab Microscopes, Laboratory Microscope, Veterinary Instruments, Inst Castration Emasculator, Biometrics & Access Control Devices, Access Control Systems.
Who are the key members and board of directors at Cirugia De Lux (India)?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nayana Puri | Director | 02-Dec-1997 | Current |
Harish Puri | Director | 02-Dec-1997 | Current |
Financial Performance of Cirugia De Lux (India).
Cirugia De Lux (India) Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 26.12% decrease. The company also saw a substantial fall in profitability, with a 11.83% decrease in profit. The company's net worth moved up by a moderate rise of 4.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Cirugia De Lux (India)?
In 2017, Cirugia De Lux (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cirugia De Lux (India)?
Unlock and access historical data on people associated with Cirugia De Lux (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cirugia De Lux (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cirugia De Lux (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.